439 related articles for article (PubMed ID: 23139352)
1. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.
Boon J; Hoy AJ; Stark R; Brown RD; Meex RC; Henstridge DC; Schenk S; Meikle PJ; Horowitz JF; Kingwell BA; Bruce CR; Watt MJ
Diabetes; 2013 Feb; 62(2):401-10. PubMed ID: 23139352
[TBL] [Abstract][Full Text] [Related]
2. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
[TBL] [Abstract][Full Text] [Related]
3. Characterising the inhibitory actions of ceramide upon insulin signaling in different skeletal muscle cell models: a mechanistic insight.
Mahfouz R; Khoury R; Blachnio-Zabielska A; Turban S; Loiseau N; Lipina C; Stretton C; Bourron O; Ferré P; Foufelle F; Hundal HS; Hajduch E
PLoS One; 2014; 9(7):e101865. PubMed ID: 25058613
[TBL] [Abstract][Full Text] [Related]
4. Plasma ceramides target skeletal muscle in type 2 diabetes.
Kirwan JP
Diabetes; 2013 Feb; 62(2):352-4. PubMed ID: 23349544
[No Abstract] [Full Text] [Related]
5. Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells.
JeBailey L; Wanono O; Niu W; Roessler J; Rudich A; Klip A
Diabetes; 2007 Feb; 56(2):394-403. PubMed ID: 17259384
[TBL] [Abstract][Full Text] [Related]
6. Ceramide accumulation in L6 skeletal muscle cells due to increased activity of ceramide synthase isoforms has opposing effects on insulin action to those caused by palmitate treatment.
Frangioudakis G; Diakanastasis B; Liao BQ; Saville JT; Hoffman NJ; Mitchell TW; Schmitz-Peiffer C
Diabetologia; 2013 Dec; 56(12):2697-701. PubMed ID: 23989724
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of lipin-1 induces insulin resistance by increasing intracellular ceramide accumulation in C2C12 myotubes.
Huang S; Huang S; Wang X; Zhang Q; Liu J; Leng Y
Int J Biol Sci; 2017; 13(1):1-12. PubMed ID: 28123341
[TBL] [Abstract][Full Text] [Related]
8. The cholesterol-lowering agent methyl-β-cyclodextrin promotes glucose uptake via GLUT4 in adult muscle fibers and reduces insulin resistance in obese mice.
Llanos P; Contreras-Ferrat A; Georgiev T; Osorio-Fuentealba C; Espinosa A; Hidalgo J; Hidalgo C; Jaimovich E
Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E294-305. PubMed ID: 25491723
[TBL] [Abstract][Full Text] [Related]
9. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.
Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ
Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694
[TBL] [Abstract][Full Text] [Related]
10. Effects of four weeks intermittent hypoxia intervention on glucose homeostasis, insulin sensitivity, GLUT4 translocation, insulin receptor phosphorylation, and Akt activity in skeletal muscle of obese mice with type 2 diabetes.
Wang Y; Wen L; Zhou S; Zhang Y; Wang XH; He YY; Davie A; Broadbent S
PLoS One; 2018; 13(9):e0203551. PubMed ID: 30199540
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat.
Fillmore N; Keung W; Kelly SE; Proctor SD; Lopaschuk GD; Ussher JR
Exp Physiol; 2015 Jun; 100(6):730-41. PubMed ID: 25786668
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of a PPAR-delta agonist to rodents worsens, not improves, maximal insulin-stimulated glucose transport in skeletal muscle of different fibers.
Cresser J; Bonen A; Chabowski A; Stefanyk LE; Gulli R; Ritchie I; Dyck DJ
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R470-9. PubMed ID: 20538899
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipid changes do not underlie fatty acid-evoked GLUT4 insulin resistance nor inflammation signals in muscle cells.
Pillon NJ; Frendo-Cumbo S; Jacobson MR; Liu Z; Milligan PL; Hoang Bui H; Zierath JR; Bilan PJ; Brozinick JT; Klip A
J Lipid Res; 2018 Jul; 59(7):1148-1163. PubMed ID: 29794037
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle.
Sanvee GM; Panajatovic MV; Bouitbir J; Krähenbühl S
Biochem Pharmacol; 2019 Jun; 164():23-33. PubMed ID: 30796916
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake.
Storz P; Döppler H; Wernig A; Pfizenmaier K; Müller G
Eur J Biochem; 1999 Nov; 266(1):17-25. PubMed ID: 10542046
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle ceramides do not contribute to physical-inactivity-induced insulin resistance.
Appriou Z; Nay K; Pierre N; Saligaut D; Lefeuvre-Orfila L; Martin B; Cavey T; Ropert M; Loréal O; Rannou-Bekono F; Derbré F
Appl Physiol Nutr Metab; 2019 Nov; 44(11):1180-1188. PubMed ID: 30889368
[TBL] [Abstract][Full Text] [Related]
17. The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice.
Bruce CR; Risis S; Babb JR; Yang C; Lee-Young RS; Henstridge DC; Febbraio MA
Endocrinology; 2013 Jan; 154(1):65-76. PubMed ID: 23183172
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance.
Turpin SM; Lancaster GI; Darby I; Febbraio MA; Watt MJ
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1341-50. PubMed ID: 16849630
[TBL] [Abstract][Full Text] [Related]
19. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.
Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017
[TBL] [Abstract][Full Text] [Related]
20. Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects.
Liang H; Tantiwong P; Sriwijitkamol A; Shanmugasundaram K; Mohan S; Espinoza S; Defronzo RA; Dubé JJ; Musi N
J Physiol; 2013 Jun; 591(11):2897-909. PubMed ID: 23529132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
